RESUMO
The extracts of five invasive plants were investigated for antifungal and antibiofilm activities against Candida albicans, C.â glabrata, C.â krusei, and C.â parapsilosis. The antifungal activity was evaluated using the microdilution assay and the antibiofilm effect by measurement of the metabolic activity. Ethanol and ethanol-water extracts of Reynoutria japonica leaves inhibited 50 % of planktonic cells at 250â µg mL-1 and 15.6â µg mL-1 , respectively. Ethanol and ethanol-water extracts of Baccharis halimifolia inhibited >75 % of the mature biofilm of C.â albicans at 500â µg mL-1 . The essential oil (EO) of B.â halimifolia leaves was the most active (50 % inhibition (IC50 ) at 4 and 74â µg mL-1 against the maturation phase and 24â h old-biofilms of C.â albicans, respectively). Oxygenated sesquiterpenes were the primary contents in this EO (62.02 %), with ß-caryophyllene oxide as the major component (37 %). Aromadendrene oxide-(2), ß-caryophyllene oxide, and (±)-ß-pinene displayed significant activities against the maturation phase (IC50 =9-310â µ mol l-1 ) and preformed 24â h-biofilm (IC50 =38-630â µ mol l-1 ) of C.â albicans with very low cytotoxicity for the first two compounds. C.â albicans remained the most susceptible species to this EO and its components. This study highlighted for the first time the antibiofilm potential of B.â halimifolia, its EO and some of its components.
Assuntos
Baccharis , Óleos Voláteis , Candida albicans , Antifúngicos/farmacologia , Óleos Voláteis/farmacologia , Etanol/farmacologia , Biofilmes , Testes de Sensibilidade MicrobianaRESUMO
Lichens, due to their symbiotic nature (association between fungi and algae), constitute a chemical factory of original compounds. Polyphenolic compounds (depsides and depsidones) are the main constituents of lichens and are exclusively biosynthesized by these organisms. A panel of 11 polyphenols was evaluated for their anti-biofilm activity against Candida albicans biofilms on the maturation phase (anti-maturation) (MMIC50) as well as on preformed 24-h-old biofilm (anti-biofilm) (MBIC50) using the XTT assay. Minimum inhibitory concentrations of compounds (MICs) against C. albicans planktonic yeast were also determined using a broth microdilution method. While none of the tested compounds were active against planktonic cells (IC50 > 100 µg/ml), three depsides slowed the biofilm maturation (MMIC50 ≤12.5 µg/ml after 48 h of contact with Candida cells). Evernic acid was able to both slow the maturation and reduce the already formed biofilms with MBIC50 ≤12.5 µg/ml after 48 h of contact with the biofilm. This compound shows a weak toxicity against HeLa cells (22%) at the minimal active concentration and no hemolytic activity at 100 µg/ml. Microscopic observations of evernic acid and optimization of its solubility were performed to further study this compound. This work confirmed the anti-biofilm potential of depsides, especially evernic acid, and allows to establish the structure-activity relationships to better explain the anti-biofilm potential of these compounds.
Assuntos
Candida albicans , Líquens , Antifúngicos , Biofilmes , Células HeLa , Humanos , Testes de Sensibilidade MicrobianaRESUMO
Electromagnetic field (EMF) treatment has proven to be effective against mineral scaling in water systems. Therefore, it should be assessed for the treatment of other deposits such as biofilms. In this study, a commercial device producing low-frequency EMF (1-10 kHz) was applied to a reactor fed with natural water for 45 days. The treatment promoted the concentration of microorganisms in suspension and limited the amount of sessile microorganisms in the biofilm, as determined by the measurement of total DNA, qPCR and microscopy. The structure of the bacterial community was assessed by t-RFLP and pyrosequencing analysis. The results showed that EMF treatment affected both planktonic and sessile community composition. EMFs were responsible for a shift in classes of Proteobacteria during development of the biofilm. It may be speculated that the EMF treatment affected particle solubility and/or microorganism hydration. This study indicated that EMFs modulated biofilm formation in natural water.
Assuntos
Biofilmes , Campos Eletromagnéticos , Plâncton , Proteobactérias , Thoracica , Animais , Biofilmes/crescimento & desenvolvimento , Biofilmes/efeitos da radiação , Biota/fisiologia , Biota/efeitos da radiação , Plâncton/fisiologia , Plâncton/efeitos da radiação , Proteobactérias/fisiologia , Proteobactérias/efeitos da radiação , Thoracica/fisiologia , Thoracica/efeitos da radiaçãoRESUMO
In the context of dental caries prevention by natural foodstuff sources, antifungal and antibiofilm activities of dry commercial extracts of cranberry fruit (Vaccinium macrocarpon Aiton) and two other red fruits (Vaccinium myrtillus L. and Malpighia punicifolia L.) were assessed on Candida albicans and Candida glabrata yeasts. When added to the culture medium, the cranberry extract displayed a significant anti-adhesion activity against Candida spp. when used at low concentrations. In addition, the pretreatment of surfaces with this extract induced an anti-adhesion activity mainly against C. glabrata yeasts and an antibiofilm activity against C. albicans. This activity was dependent on concentration, species, and strain. A phytochemical investigation bioguided by anti-adhesion tests against the two Candida species was carried out on crude cranberry juice to determine the active fractions. Three subfractions enriched in proanthocyanidins showed an anti-adhesion activity at low concentrations. This study investigated for the first time the interest of crude extracts of cranberry and cranberry juice fractions to prevent biofilms of C. glabrata. It highlighted the potency of consuming this fruit and using it as a source of anti-adhesion agents.
Assuntos
Biofilmes/efeitos dos fármacos , Candida/efeitos dos fármacos , Candida/fisiologia , Candidíase Bucal/prevenção & controle , Extratos Vegetais/farmacologia , Vaccinium macrocarpon/química , Antifúngicos/farmacologia , Fracionamento Químico , Adesões Focais/efeitos dos fármacos , Frutas/química , Humanos , Testes de Sensibilidade Microbiana , Propriedades de SuperfícieRESUMO
Legionella pneumophila, the causative agent of Legionnaires' disease, is ubiquitously found in aquatic environments, associated with free living amoebae. Trophozoite forms of the genus Acanthamoeba have been shown to support the intracellular growth of Legionella while it has been proposed that cyst forms are related to survival in harsh environments. This underlines that amoebae are of primary importance in Legionella spreading. In this study, we followed the survival of L. pneumophila Lens over 6 months in a poor medium, with or without Acanthamoeba castellanii. The results demonstrated that L. pneumophila Lens could survive for at least 6 months in association with A. castellanii and that cultivable bacteria are to be found within expelled vesicles rather than within cysts. Our findings suggest that vesicles might be further studied in order to elucidate their production and their role in the environmental spreading of Legionella.
Assuntos
Acanthamoeba castellanii/microbiologia , Legionella pneumophila/crescimento & desenvolvimento , Viabilidade Microbiana , Vesículas Transportadoras/microbiologia , Acanthamoeba castellanii/fisiologia , Animais , Humanos , Estágios do Ciclo de Vida/fisiologia , TrofozoítosRESUMO
OBJECTIVES: Amoebic keratitis is difficult to treat, without total efficacy in some patients because of cysts that are less susceptible than trophozoites to the usual treatments. We investigated here the in vitro effectiveness of caspofungin, a new antifungal, against three species of Acanthamoeba. METHODS: Trophozoites and cysts of Acanthamoeba castellanii, Acanthamoeba culbertsoni and Acanthamoeba polyphaga were incubated with caspofungin at concentrations varying from 16 to 500 mg/L. RESULTS: The trophozoites of the three tested species were susceptible in vitro to caspofungin at a concentration of 250 mg/L (206 microM). Furthermore, this drug was cysticidal at a concentration of 500 mg/L (412 microM) against A. castellanii and A. culbertsoni. CONCLUSIONS: Caspofungin could represent, if in vivo studies confirm its efficacy, a new anti-Acanthamoeba compound.
Assuntos
Acanthamoeba/efeitos dos fármacos , Peptídeos Cíclicos/farmacologia , Trofozoítos/efeitos dos fármacos , Ceratite por Acanthamoeba/tratamento farmacológico , Animais , Caspofungina , Equinocandinas , LipopeptídeosRESUMO
OBJECTIVES: Some manifestations of candidiasis are associated with the formation of biofilms on inert or biological surfaces and the intrinsic resistance of Candida albicans biofilms to the most commonly used antifungal agents has been demonstrated. In this study, we report on the influence of the growth of C. albicans in medium containing a sub-inhibitory concentration (MIC/2) of caspofungin, on subsequent fungal adherence to plastic coated with extracellular matrix (ECM) proteins. METHODS: Eleven strains of C. albicans were studied: six strains were susceptible to fluconazole in vitro and five strains were resistant to this antifungal agent. RESULTS: Caspofungin induced a decrease in the adherence of all the tested strains that were susceptible to fluconazole but induced a decrease in the adherence of only 60% of the fluconazole-resistant strains. CONCLUSIONS: This study demonstrated the anti-adherent activity of caspofungin but indicated a reduced effect in the case of in vitro fluconazole resistance. These results indicated a possible relationship between the efficiency of caspofungin to inhibit the first step of the development of C. albicans biofilm and the resistance of C. albicans to fluconazole in vitro.
Assuntos
Antifúngicos/farmacologia , Candida albicans/efeitos dos fármacos , Proteínas da Matriz Extracelular/metabolismo , Peptídeos Cíclicos , Peptídeos/farmacologia , Biofilmes/efeitos dos fármacos , Caspofungina , Farmacorresistência Fúngica Múltipla , Equinocandinas , Fluconazol/farmacologia , Implantes Experimentais , Lipopeptídeos , Plásticos , PoliestirenosRESUMO
Iridal, a triterpenoidic compound extracted from Iris germanica L., was previously shown to have an interesting activity on two cultured human tumor cell lines (A2780 and K562). In the present work, this same product was tested in vitro on Plasmodium falciparum chloroquine-resistant and -sensitive strains, in vivo on P. vinckei, and on some Candida albicans and C. parapsilosis strains too. The IC(50) obtained in vitro on human malaria strain ranged from 1.8 to 26.0 microg/ml and the ED(50) in vivo is about 85 mg/kg/day by intraperitoneal route. The minimal inhibitory concentrations were higher than to 50 microg/ml, whatever the strain of yeast tested. This product presents an antiplasmodial activity similar to that obtained with extracts from the plant Azadirachta indica classically taken as reference in malaria phytomedicine. Conversely iridal shows no important antifungal activity. The specific activity of iridal on human malaria parasite and on tumor cell lines is discussed.